Reduction of the concentrations of prostaglandins E 2 and F 2 , and thromboxane B 2 in cultured rat hepatocytes treated with the peroxisome proliferator ciprofibrate

Author： Lai K.L.   Glauert H.P.  

Publisher： Elsevier

ISSN： 0378-4274

Source： Toxicology Letters, Vol.85, Iss.3, 1996-06, pp. : 143-149

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stimulation of the DNA binding activity of AP-1 by the peroxisome proliferator ciprofibrate and eicosanoids in cultured rat hepatocytes

By Hong J.T.   Glauert H.P.  

Toxicology, Vol. 131, Iss. 2, 1998-11 ,pp. : 99-107

Elsevier

Access to resources Recommend Favorite

Effect of the peroxisome proliferator ciprofibrate on hepatic cyclooxygenase and phospholipase A 2 in rats

By Leung L.K.   Glauert H.P.  

Toxicology, Vol. 126, Iss. 1, 1998-02 ,pp. : 65-73

Elsevier

Access to resources Recommend Favorite

Lack of correlation between hepatic prostaglandin concentrations and DNA synthesis after the administration of phenobarbital and the peroxisome proliferator ciprofibrate in rats

By Leung L.K.   Glauert H.P.  

Toxicology, Vol. 123, Iss. 1, 1997-11 ,pp. : 101-109

Elsevier

Access to resources Recommend Favorite

Effect of Peroxisome Proliferator Nafenopin on the Cytotoxicity of Dihaloalkanes in Isolated Rat Hepatocytes

By Voskoboinik I.   Drew R.   Ahokas J.T.  

Toxicology in Vitro, Vol. 10, Iss. 5, 1996-10 ,pp. : 577-584

Elsevier

Access to resources Recommend Favorite

Characterization of peroxisome proliferator-activated receptor alpha in normal rat mammary gland and 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine-induced mammary gland tumors from rats fed high and low fat diets

By Roberts-Thomson S.J.   Snyderwine E.G.  

Toxicology Letters, Vol. 118, Iss. 1, 2000-12 ,pp. : 79-86

Elsevier

Access to resources Recommend Favorite